Stock Market News Briefs: Affymax, Amgen, MetLife, Regeneron Pharmaceuticals, SAP Aktiengesellschaft Systeme, Anwendungen, Produ, SuccessFactors
Shares of bio-pharma company Affymax Inc. (NASDAQ:AFFY) increased 19.24% after FDA found Affymax’s experimental anemia medication is as effective as drugs by Amgen, Inc. (NASDAQ:AMGN) Discovery Group LLC announced it had acquired a 5.8% stake in software maker Intralinks Holdings Inc. (IL). Following this development, shares of Intralinks Holdings gained 9.63% to close [...]
Shares of bio-pharma company Affymax Inc. (NASDAQ:AFFY) increased 19.24% after FDA found Affymax’s experimental anemia medication is as effective as drugs by Amgen, Inc. (NASDAQ:AMGN)
Discovery Group LLC announced it had acquired a 5.8% stake in software maker Intralinks Holdings Inc. (IL). Following this development, shares of Intralinks Holdings gained 9.63% to close at $5.69
Share prices of web-based software company SuccessFactors Inc. … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards